Article Contents ::
- 1 Details About Generic Salt :: Dtap
- 2 Main Medicine Class::
- 3 (diff-THEER-ee-uh/TET-ah-nus toxoids/ay-SELL-you-luhr per-TUSS-iss/hem-AHF-ill-us in-flew-EN-zuh vaccine) TriHIBit Injection 10 mcg Haemophilus influenza type b purified capsular polysaccharide conjugated to 24 mcg inactivated tetanus toxoid, 6.7 Lf diphtheria toxoid, 5 Lf tetanus toxoid, 46.8 mcg pertussis antigens per 0.5 mL. Supplied as ActHIB (Haemophilus b conjugate vaccine [tetanus toxoids combined]) with Tripedia (diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed [(DTaP]). For prescribing information, refer to the Haemophilus b Conjugate Vaccine monograph and the Diphtheria/Tetanus Toxoids/Acellular Pertussis Vaccine monograph. Class: Vaccine
- 4 Drugs Class ::
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details About Generic Salt :: Dtap
Main Medicine Class::
(diff-THEER-ee-uh/TET-ah-nus toxoids/ay-SELL-you-luhr per-TUSS-iss/hem-AHF-ill-us in-flew-EN-zuh vaccine)
TriHIBit
Injection
10 mcg
Haemophilus influenza type b purified capsular polysaccharide conjugated to 24 mcg inactivated tetanus toxoid, 6.7 Lf diphtheria toxoid, 5 Lf tetanus toxoid, 46.8 mcg pertussis antigens per 0.5 mL. Supplied as ActHIB (Haemophilus b conjugate vaccine [tetanus toxoids combined]) with Tripedia (diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed [(DTaP]). For prescribing information, refer to the Haemophilus b Conjugate Vaccine monograph and the Diphtheria/Tetanus Toxoids/Acellular Pertussis Vaccine monograph.
Class: Vaccine
Drugs Class ::
Action DTaP: Diphtheria and tetanus toxoids induce antibodies against toxins made by Corynebacterium diphtheriae and Clostridium tetani. Pertussis vaccine: Protects against Bordetella pertussis. Haemophilus B conjugate vaccine: Induces active immunity against Hib infection.
Indications for Drugs ::
Indications Active immunization of children 15 to 18 mo who have previously been immunized against diphtheria, tetanus, and pertussis with 3 doses consisting of diphtheria and tetanus toxoids and whole cell pertussis or DTaP vaccine and 3 doses or fewer of ActHIB within the first year of life for the prevention of invasive diseases caused by Haemophilus influenzae type b or by diphtheria, tetanus, and pertussis. Do not administer to infants younger than 15 mo.
Drug Dose ::
Route/Dosage
IM Administer in outer aspect of the mid-thigh or deltoid, not into the gluteal area or other areas where there may be a nerve trunk. First, second, and third dose: at age 2, 4, and 6 mo immunize with ActHIB reconstituted with DTP or saline diluent (0.4% sodium chloride). Fourth dose: at 15 to 18 mo immunize with ActHIB reconstituted with DTP or Tripedia or with saline diluent (0.4% sodium chloride). Fifth dose: at 4 to 6 yr immunize with Tripedia or DTP. Vaccinate preterm infants according to their chronological age from birth.
Contraindication ::
Contraindications For prescribing information, refer to the Haemophilus b Conjugate Vaccine monograph and the Diphtheria/Tetanus Toxoids/Acellular Pertussis Vaccine monograph.
Drug Precautions ::
Precautions
For prescribing information, refer to the Haemophilus b Conjugate Vaccine monograph and the Diphtheria/Tetanus Toxoids/Acellular Pertussis Vaccine monograph.
PATIENT CARE CONSIDERATIONS |
|
Drug Side Effects ::
Adverse Reactions
For prescribing information, refer to the Haemophilus b Conjugate Vaccine monograph and the Diphtheria/Tetanus Toxoids/Acellular Pertussis Vaccine monograph.
Drug Mode of Action ::
Action DTaP: Diphtheria and tetanus toxoids induce antibodies against toxins made by Corynebacterium diphtheriae and Clostridium tetani. Pertussis vaccine: Protects against Bordetella pertussis. Haemophilus B conjugate vaccine: Induces active immunity against Hib infection.
Drug Interactions ::
Interactions
For prescribing information, refer to the Haemophilus b Conjugate Vaccine monograph and the Diphtheria/Tetanus Toxoids/Acellular Pertussis Vaccine monograph.
Adverse Reactions
For prescribing information, refer to the Haemophilus b Conjugate Vaccine monograph and the Diphtheria/Tetanus Toxoids/Acellular Pertussis Vaccine monograph.
Precautions
For prescribing information, refer to the Haemophilus b Conjugate Vaccine monograph and the Diphtheria/Tetanus Toxoids/Acellular Pertussis Vaccine monograph.
PATIENT CARE CONSIDERATIONS |
|
Administration/Storage
- For prescribing information, refer to the Haemophilus b Conjugate Vaccine monograph and the Diphtheria/Tetanus Toxoids/Acellular Pertussis Vaccine monograph.
Assessment/Interventions
- For prescribing information, refer to the Haemophilus b Conjugate Vaccine monograph and the Diphtheria/Tetanus Toxoids/Acellular Pertussis Vaccine monograph.
Patient/Family Education
- For prescribing information, refer to the Haemophilus b Conjugate Vaccine monograph and the Diphtheria/Tetanus Toxoids/Acellular Pertussis Vaccine monograph.
Drug Assesment ::
Assessment/Interventions
- For prescribing information, refer to the Haemophilus b Conjugate Vaccine monograph and the Diphtheria/Tetanus Toxoids/Acellular Pertussis Vaccine monograph.
Drug Storage/Management ::
Administration/Storage
- For prescribing information, refer to the Haemophilus b Conjugate Vaccine monograph and the Diphtheria/Tetanus Toxoids/Acellular Pertussis Vaccine monograph.
Drug Notes ::
Patient/Family Education
- For prescribing information, refer to the Haemophilus b Conjugate Vaccine monograph and the Diphtheria/Tetanus Toxoids/Acellular Pertussis Vaccine monograph.